Pfizer Inc. (NEO:PFE)

Canada flag Canada · Delayed Price · Currency is CAD
10.32
+0.05 (0.49%)
Apr 24, 2025, 9:57 AM EDT
-16.44%
Market Cap 176.13B
Revenue (ttm) 91.55B
Net Income (ttm) 11.56B
Shares Out n/a
EPS (ttm) 2.03
PE Ratio 15.24
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 73,191
Average Volume 101,052
Open 10.39
Previous Close 10.27
Day's Range 10.25 - 10.39
52-Week Range 9.68 - 14.73
Beta 0.60
RSI 38.50
Earnings Date Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Cboe Canada
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.